Nothing Special   »   [go: up one dir, main page]

ES2058067T3 - Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados. - Google Patents

Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados.

Info

Publication number
ES2058067T3
ES2058067T3 ES87100856T ES87100856T ES2058067T3 ES 2058067 T3 ES2058067 T3 ES 2058067T3 ES 87100856 T ES87100856 T ES 87100856T ES 87100856 T ES87100856 T ES 87100856T ES 2058067 T3 ES2058067 T3 ES 2058067T3
Authority
ES
Spain
Prior art keywords
didesoxi
fluor
talopyrose
derivatives
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87100856T
Other languages
English (en)
Inventor
Hamao Umezawa
Sumio Umezawa
Tsutomu Tsuchiya
Tomio Takeuchi
Yasushi Takagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Application granted granted Critical
Publication of ES2058067T3 publication Critical patent/ES2058067T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TRATA DE LA PREPARACION DE LA 2,6-DIDESOXI-2-FLUOR-L-TALOPIRANOSA Y SUS DERIVADOS I-SUSTITUIDOS, INCLUYENDO HALUROS DE METIL2,6-DIDESOXI-2-FLUOR-L-TALOPIRANOSA Y DE 3,4-DI -OPROTEGIDA-2,6-DIDESOXI -2-FLUOR-L-TALOPIRANOSA. ESTOS NUEVOS COMPUESTOS SON UTILES COMO INTERMEDIOS PARA LA SINTESIS DE NUEVOS COMPUESTOS QUE TIENEN ACTIVIDAD ANTITUMORAL,EN ESPECIAL LA 7-O-(2,6-DIDESOXI -2-FLUOR-ALFA-L-TALOPIRANOSIL)- DAUNOMICINONA O -ADRIAMICINONA. LA 2,6-DIDESOXI-2-FLUOR- L-TALOPIRANOSA MUESTRA ACTIVIDAD ANTIBACTERIANA Y AL IGUAL QUE SUS DERIVADOS I-SUSTITUIDOS PUEDE PREPARARSE A PARTIR DE L-FUCOSA MEDIANTE UN PROCEDIMIENTO DE VARIAS ETAPAS.
ES87100856T 1986-01-22 1987-01-22 Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados. Expired - Lifetime ES2058067T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61009893A JPH0660189B2 (ja) 1986-01-22 1986-01-22 ２，６−ジデオキシ−２−フルオロ−ｌ−タロピラノ−ス又はその誘導体とその製造法

Publications (1)

Publication Number Publication Date
ES2058067T3 true ES2058067T3 (es) 1994-11-01

Family

ID=11732807

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87100856T Expired - Lifetime ES2058067T3 (es) 1986-01-22 1987-01-22 Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados.

Country Status (6)

Country Link
US (1) US5034517A (es)
EP (1) EP0230322B1 (es)
JP (1) JPH0660189B2 (es)
CA (1) CA1297478C (es)
DE (1) DE3786562T2 (es)
ES (1) ES2058067T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517293B2 (ja) * 1987-06-25 1996-07-24 メクト株式会社 細胞、組織修復剤
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
KR100211417B1 (ko) * 1990-11-30 1999-10-01 유충식 L-탈로피라노시드 유도체 및 그의 제조방법
JPH0912590A (ja) * 1995-06-23 1997-01-14 Microbial Chem Res Found ４−アミノ−２，４，６−トリデオキシ−２−フルオロ−マンノピラノシル基を有する新規アンスラサイクリン誘導体
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
EP2282773B1 (en) 2008-05-02 2014-01-15 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
JP5334484B2 (ja) * 2008-07-25 2013-11-06 国立大学法人 長崎大学 ラムノシドエステル誘導体およびその製造方法
TR201902439T4 (tr) 2010-08-05 2019-03-21 Seattle Genetics Inc Fukoz analogları kullanarak in vivo protein fukosilasyonunun inhibisyon yöntemleri .
EP2887947B1 (en) 2012-08-23 2019-06-05 Seattle Genetics, Inc. Fucose analogues for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427664A (en) * 1981-05-29 1984-01-24 The United States Of America As Represented By The Department Of Health And Human Services 2'Halo derivatives of daunomycin, desmethoxy daunomycin, adriamycin and carminomycin
GR79729B (es) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS59181295A (ja) * 1983-03-30 1984-10-15 Rikagaku Kenkyusho 新規デオキシフルオロ糖及びその製造法
JPH0631298B2 (ja) * 1985-12-18 1994-04-27 財団法人微生物化学研究会 新規アンスラサイクリン誘導体，抗腫瘍剤，及び製造法

Also Published As

Publication number Publication date
EP0230322A3 (en) 1988-11-30
EP0230322A2 (en) 1987-07-29
JPS62145096A (ja) 1987-06-29
DE3786562T2 (de) 1993-12-02
DE3786562D1 (de) 1993-08-26
CA1297478C (en) 1992-03-17
US5034517A (en) 1991-07-23
EP0230322B1 (en) 1993-07-21
JPH0660189B2 (ja) 1994-08-10

Similar Documents

Publication Publication Date Title
AR227063A1 (es) Procedimiento para la produccion de nuevos acidos 7-amino-1-ciclopropil-4-oxo-1,4-dihidro-(1,6-y 1,8-naftiridina o quinolina)-3-carboxilicos
ATE258379T1 (de) Nukleinsäure, die für einen tumor abstossungsantigenvorläufer kodiert
MX9205573A (es) Nuevas 9-amino-7-(amino substituido)-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composicion farmaceutica que las contiene
DE3856515D1 (de) Zwischenprodukte zur Herstellung von benzoheterocyclischen Verbindungen
ATE131161T1 (de) Substanz pf 1022, verfahren zu ihrer herstellung und diese substanz enthaltende anthelmintische zusammensetzung.
ES542322A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
NO854085L (no) Liposomer fra syntetiske lipider.
MX9205532A (es) Nuevas 7-sustituidas-9-amino sustituidas 6-desmetil-6-desoxitetraciclinas, metodo para su producciony composicion farmaceutica que las contiene.
AR003962A1 (es) Dihidrodibenzo/b,f/azepinas útiles en el tratamiento de algunos desórdenes del sistema nervioso central y períferico, método para preparar dichos compuestos y sus composiciones farmacéuticas,y, sus usos
HUT35659A (en) Process for producing 4-amino-methylene-chromane- and-chromene-derivatives and pharmaceutical compositions containing them as active agents
ES2058067T3 (es) Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados.
GR78987B (es)
IL80853A (en) Process for the production of podophyllotoxin and related compounds,certain intermediates therefor and their preparation
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
FR2608607B1 (fr) Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
ES2036627T3 (es) Procedimiento para la preparacion de aldehidos biciclicos.
EP0229644A3 (en) Method of use for diltiazem, verapamil or nifedipine having activity for the treatment of stroke
IT1226300B (it) Processo per la preparazione di intermedi per la sintesi del diltiazem.
HUT63734A (en) Fish-breeding method
ATE85612T1 (de) Verbessertes verfahren zur katalytischen hydrierung von dahnp und zur herstellung von dafhp.
ATE15050T1 (de) Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
GR1001125B (el) Μεθοδος δια την εις βιομηχανικη κλιμακα παραγωγην της βμυ 21502.
MX9602804A (es) Derivados del 3-aril-alquenil-1,2,4-oxadiazol y su uso como parasiticidas para animales.
BG47345A3 (en) Method for preparing of dialkyloxalacetates
PT74455B (en) Process for preparing novel substances having carcinostatic and immunostimulating activity and of a carcinostatic agent containing same

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 230322

Country of ref document: ES